Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access
Login for full access:
Plenary Session 2: Targeting the PI3K Pathway
- Sort by:
- Browse by:
- Free
- audio + slides
Targeting the PI3K pathway in cancer
Dr. William R. Sellers
Novartis Institutes for BioMedical Research, Cambridge, MA
- Free
- audio + slides
Growth control by the mTOR pathway
Dr. David M. Sabatini
MIT Whitehead Institute for Biomedical Research, Cambridge, MA
- Free
- audio + slides
Targeting PI3K in Breast Cancer
Dr. Jean J. Zhao
Dana-Farber Cancer Institute, Boston, MA
- Free
- audio + slides
Finding biomarkers of resistance to EGFR targeted therapy in cancer
Dr. René Bernards
The Netherlands Cancer Institute, Amsterdam, The Netherlands